CasNo.615-18-9,2-chlorobenzoxazole,(615-18-9) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: ≥98%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

2-chlorobenzoxazole 2-chlorobenzoxazole 615-18-9 2-chlorobenzoxazole 615-18-9

Quick Details

Appearance:White to teary white solid powder
Application:For nucleotides
PackAge:Packaging according to actual needs
ProductionCapacity:100|Metric Ton|Day
Storage:Inert atmosphere,2-8℃
Transportation:by sea or by air

Superiority:

Product name:2-chlorobenzoxazole
CAS:615-18-9
Molecular formula:C7H4ClNO
Molecular weight:153.57
EINECS:210-414-5
MDL No:MFCD00005766
Storage conditions:Inert atmosphere,2-8℃
Solubility:
Exterior:White to teary white solid powder
Density:1.345 g/mL at 2℃(lit.)
Acidity coefficient(pKa):0.62±0.10(Predicted)
Stability:
Melting point:7℃(lit.)
Specific rotation:
Boiling point：201-202℃(lit.)

The Core Team of XH Medic Tech Co.,Ltd. was established on January 20,2022. The company is committed to the research and production of various series of nucleoside/nucleotide blocks (modified nucleoside, monomer, Dimer, Trimer, LNA, etc.), nucleotide phosphate (monophosphate,triphosphate)，GalNAc，R/S thiophosphate oligonucleotide, transfection reagent, etc.The company has a strong R&D capabilityThe director of the company’s research fellows is mainly composed by postdoctoral researcher von the Chinese Academy of Sciences Since its establishment XH has established long-term cooperative relations with companies at home and abroad.XH has been and continue to develop new products, improve process technology to empower customers.

Details:

Product name:2-chlorobenzoxazole
CAS:615-18-9
Molecular formula:C7H4ClNO
Molecular weight:153.57
EINECS:210-414-5
MDL No:MFCD00005766
Storage conditions:Inert atmosphere,2-8℃
Solubility:
Exterior:White to teary white solid powder
Density:1.345 g/mL at 2℃(lit.)
Acidity coefficient(pKa):0.62±0.10(Predicted)
Stability:
Melting point:7℃(lit.)
Specific rotation:
Boiling point：201-202℃(lit.)

The Core Team of XH Medic Tech Co.,Ltd. was established on January 20,2022. The company is committed to the research and production of various series of nucleoside/nucleotide blocks (modified nucleoside, monomer, Dimer, Trimer, LNA, etc.), nucleotide phosphate (monophosphate,triphosphate)，GalNAc，R/S thiophosphate oligonucleotide, transfection reagent, etc.The company has a strong R&D capabilityThe director of the company’s research fellows is mainly composed by postdoctoral researcher von the Chinese Academy of Sciences Since its establishment XH has established long-term cooperative relations with companies at home and abroad.XH has been and continue to develop new products, improve process technology to empower customers.